Related Experiment Video
Updated: Dec 27, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA
Xiao Yang1,2, Sen Zhang1,2, Changyu He1
1Division of Gastrointestinal and Colorectal Surgery, Ruijin Hospital, Department of General Surgery, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200001, China.
Background:
N6-methyladenosine (m6A) is the most prevalent RNA epigenetic regulation in eukaryotic cells. However, understanding of m6A in colorectal cancer (CRC) is very limited. We designed this study to investigate the role of m6A in CRC.
Methods:
Expression level of METTL14 was extracted from public database and tissue array to investigate the clinical relevance of METTL14 in CRC. Next, gain/loss of function experiment was used to define the role of METTL14 in the progression of CRC. Moreover, transcriptomic sequencing (RNA-seq) was applied to screen the potential targets of METTL14. The specific binding between METTL14 and presumed target was verified by RNA pull-down and RNA immunoprecipitation (RIP) assay. Furthermore, rescue experiment and methylated RNA immunoprecipitation (Me-RIP) were performed to uncover the mechanism.
Results:
Clinically, loss of METTL14 correlated with unfavorable prognosis of CRC patients. Functionally, knockdown of METTL14 drastically enhanced proliferative and invasive ability of CRC cells in vitro and promoted tumorigenicity and metastasis in vivo. Mechanically, RNA-seq and Me-RIP identified lncRNA XIST as the downstream target of METTL14. Knockdown of METTL14 substantially abolished m6A level of XIST and augmented XIST expression. Moreover, we found that m6A-methylated XIST was recognized by YTHDF2, a m6A reader protein, to mediate the degradation of XIST. Consistently, XIST expression negatively correlated with METTL14 and YTHDF2 in CRC tissues.
Conclusion:
Our findings highlight the function and prognostic value of METTL14 in CRC and extend the understanding of the importance of RNA epigenetics in cancer biology.
Insights
Loss of METTL14 in colorectal cancer (CRC) correlates with poor prognosis. METTL14 regulates cancer progression by affecting the m6A modification of lncRNA XIST, highlighting its role in RNA epigenetics.
Area of Science:
- Molecular Biology
- Epigenetics
- Cancer Research
Background:
- N6-methyladenosine (m6A) is a key RNA epigenetic modification in eukaryotes.
- The role of m6A in colorectal cancer (CRC) remains largely unexplored.
Purpose of the Study:
- To investigate the clinical relevance and functional role of METTL14 in colorectal cancer.
- To elucidate the molecular mechanisms underlying METTL14's function in CRC progression.
Main Methods:
- Analysis of METTL14 expression in CRC patient data and tissues.
- In vitro and in vivo gain/loss of function experiments.
- RNA sequencing (RNA-seq), RNA pull-down, RNA immunoprecipitation (RIP), and methylated RNA immunoprecipitation (Me-RIP) assays.
Main Results:
- Loss of METTL14 expression is associated with unfavorable prognosis in CRC patients.
- METTL14 knockdown enhances CRC cell proliferation, invasion, tumorigenicity, and metastasis.
- METTL14 targets lncRNA XIST, regulating its m6A modification and expression, and interacts with YTHDF2 to control XIST stability.
Conclusions:
- METTL14 plays a crucial role in CRC progression and serves as a prognostic biomarker.
- This study enhances the understanding of RNA epigenetics' importance in cancer biology, specifically in CRC.
More Related Videos
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
08:27A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome
Published on: May 22, 2019
Related Concept Videos
Inheritance of Chromatin Structures
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Epigenetic Regulation